NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science

Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and most … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science”

Pressure Biosciences, Inc. (PBIO) Starts Presentation at LD Micro Main Event

Pressure Biosciences (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating … Continue reading “Pressure Biosciences, Inc. (PBIO) Starts Presentation at LD Micro Main Event”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Targets Nanoemulsions Market Through Collaboration with Phasex Corp.

Pressure BioSciences (OTCQB: PBIO) recently entered into a strategic collaboration with Phasex Corporation. The company’s goal is to combine its patented Ultra Shear Technology (“UST”) with Phasex’ Supercritical Fluid (“SCF”) processing to cultivate stable, water-soluble nanoemulsions. An article discussing this reads: “Emulsions are mixtures of two or more liquids (e.g., oils and water) that cannot … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Targets Nanoemulsions Market Through Collaboration with Phasex Corp.”

Pressure BioSciences Inc. (PBIO) Forms Strategic Collaboration with Phasex Corporation to Address Markets for Nanoemulsions

Goal is to combine PBIO’s patented Ultra Shear Technology (UST) with Phasex’ Supercritical Fluid (SCF) processing to develop stable, water-soluble nanoemulsions As part of this collaboration, PBIO and Phasex seek to develop stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil CEO of PBIO sees collaboration leading to a ‘Value-add’ for Phasex customers and a … Continue reading “Pressure BioSciences Inc. (PBIO) Forms Strategic Collaboration with Phasex Corporation to Address Markets for Nanoemulsions”

NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Q3 Top Line Marks Record Quarterly Growth

Pressure BioSciences (OTCQB: PBIO) capitalized on a strong demand for its proprietary pressure-based laboratory instruments and related products, reporting record quarterly revenues of more than $600,000 for Q32017. An article discussing this reads: “Among recent highlights of the company’s operations, Pressure BioSciences set up its first Center of Excellence in Asia, which should have a … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Q3 Top Line Marks Record Quarterly Growth”

Pressure BioSciences, Inc. (PBIO) Achieves Record Quarterly Revenue Growth

Quarterly total revenue exceeds $600,000 for the first time ever Consumable sales up 158 percent year-over-year New Center of Excellence in Asia expected to speed expansion in China Recently patented Ultra Shear Technology platform can be used to create or improve a wide range of medical, consumer, and industrial products, through the preparation of high … Continue reading “Pressure BioSciences, Inc. (PBIO) Achieves Record Quarterly Revenue Growth”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Posts Q3 2017 Financial Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”) reported financial results for the third quarter of 2017 today, along with a business update and limited guidance regarding its expected revenue for the rest of FY 2017. Among other highlights, the company reported a record-breaking total revenue of $646,061, an increase of 21% from $535,334 in the third quarter … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Posts Q3 2017 Financial Results, Provides Business Update”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference Regarding Q3 2017 Financial Results

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, announced this morning that the company will host a conference call, during which the company will provide a business update and discuss financial results for the third quarter of 2017. The call will … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference Regarding Q3 2017 Financial Results”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Progresses in Global Life Sciences Industry

Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative solutions for the worldwide life sciences industry. The company is advancing in the industry, with its patented high pressure cycling technology. PBIO also recently received patents for its Ultra Shear Technology. An article discussing this reads: “Pressure BioSciences, which completed 2016 … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Progresses in Global Life Sciences Industry”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Names First Center of Excellence in China, Eyes Significant Expansion

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced that Professor Tiannan Guo’s laboratory at Westlake Institute for Advanced Study (“WIAS”) has been named the company’s first Center of Excellence (“CoE”) in China. … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Names First Center of Excellence in China, Eyes Significant Expansion”

Contact us: 212.418.1217